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Background
The preventive treatment of emergency situations and
complications caused by chronic alcoholism presents
psychiatrists and physicians with a great challenge.
Delirium tremens is a potentially fatal form of alcohol
withdrawal (mortality rate 5%-15%) that usually occurs
in patients with heavy and chronic alcohol abuse.
Materials and methods
Our research took place in a private psychiatric clinic
(2005-2009) and focused on the effectiveness of a certain
pharmacological combination administered to a sample
of 37 patients, in an attempt to control the alcohol with-
drawal syndrome. The pharmacological combination
comprised 30mg-60mg Chlordiazepoxide hydrochloride,
300mg-500mg Triapride hydrochloride, 300mg-500mg
Hydroxyzine hydrochloride, 576mg Clometiazol, 600mg-
1200mg Oxcarbazepine and B1+B2+B12 complex daily.
Additionally, the patients received antidepressants and
cardiovascular drugs.
Results
None of our sample patients developed any delirium tre-
mens symptoms. The average duration of the drug com-
bination administration was 11 days followed by a
gradually decreasing dose until the maintenance dosage
was reached.
Conclusions
When compared to other suggested drug treatments this
method proved to be highly effective in delirium tre-
mens prevention
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